Randomized Controlled Trial of Perioperative Telemonitoring of Patient Generated Health Data in Gastrointestinal Oncologic Surgery: Assessing Overall Feasibility and Acceptability.
Randomized Controlled Trial of Perioperative Telemonitoring of Patient Generated Health Data in Gastrointestinal Oncologic Surgery: Assessing Overall Feasibility and Acceptability.
复制标题
胃肠道肿瘤手术中患者生成健康数据的围手术期远程监控试验的随机对照试验：评估整体可行性和可接受性。
DOI：
10.1007/s00268-023-07179-y
复制
发表时间：
2023-12
影响因子：
2.6
通讯作者：
Melstrom, Laleh G.
中科院分区：
文献类型：
--
作者：
Limbach, Kristen;Esslin, Patricia;Sun, Virginia;Fan, Darrell;Kaiser, Andreas M.;Paz, I. Benjamin;Raoof, Mustafa;Lewis, Aaron;Melstrom, Kurt A.;Lai, Lily;Woo, Yanghee;Singh, Gagandeep;Fong, Yuman;Melstrom, Laleh G.
自2019冠状病毒病疫情开始以来，远程监护和远程医疗平台的使用一直受到稳步增长的关注，实施率持续上升[1]。虽然这项技术有可能应用于广泛的医疗条件和护理环境[1-4]，但远程远程监护可能对安全性和价值产生重大影响的一个领域是围手术期[5]。在此背景下的远程监护研究描述了患者生成的健康数据（PGHD）的使用，特别是在出院后，包括使用活动跟踪器/步计数器以及电子患者报告结局（ePRO）[6]。到目前为止，结果令人鼓舞。例如，2021年的一项荟萃分析研究了移动的医疗技术在术后远程监测中的应用，发现实施此类监测技术既可行，又与显著减少急诊室就诊和再入院相关[5]。然而，可能获得最大利益的确切人群尚未得到充分阐明。
Since the beginning of the COVID-19 pandemic, the use of remote telemonitoring and telehealth platforms has been of steadily increasing interest, and implementation continues to rise [1]. Although this technology has the potential to be applied in a wide spectrum of medical conditions and care environments [1–4], one area in which remote telemonitoring may have a significant impact on both safety and value is in the perioperative period [5]. Studies of telemonitoring in this context have described the use of patient-generated health data (PGHD), particularly after discharge, including the use of activity trackers/step counters as well as electronic patient-reported outcomes (ePROs)[6]. Results have so far been encouraging. For example, a 2021 meta-analysis examining the use of mobile health technology for remote telemonitoring after surgery found that implementation of such monitoring technology was both feasible and associated with significantly fewer emergency department visits and readmissions [5]. However, the exact populations who may derive the greatest benefit have yet to be fully elucidated.
登录
查看更多内容
影响因子：
7.7
作者：
Garfan S;Alamoodi AH;Zaidan BB;Al-Zobbi M;Hamid RA;Alwan JK;Ahmaro IYY;Khalid ET;Jumaah FM;Albahri OS;Zaidan AA;Albahri AS;Al-Qaysi ZT;Ahmed MA;Shuwandy ML;Salih MM;Zughoul O;Mohammed KI;Momani F
通讯作者：
Momani F
影响因子：
3.5
作者：
Neuhauser, Linda;Kreps, Gary L.
通讯作者：
Kreps, Gary L.
影响因子：
4.5
作者：
van Hout, Ben;Janssen, M. F.;Pickard, A. Simon
通讯作者：
Pickard, A. Simon
影响因子：
3.7
作者：
Jonker LT;Lahr MMH;Oonk MHM;de Bock GH;van Leeuwen BL
通讯作者：
van Leeuwen BL
影响因子：
39
作者：
Ong MK;Romano PS;Edgington S;Aronow HU;Auerbach AD;Black JT;De Marco T;Escarce JJ;Evangelista LS;Hanna B;Ganiats TG;Greenberg BH;Greenfield S;Kaplan SH;Kimchi A;Liu H;Lombardo D;Mangione CM;Sadeghi B;Sadeghi B;Sarrafzadeh M;Tong K;Fonarow GC;Better Effectiveness After Transition–Heart Failure (BEAT-HF) Research Group
通讯作者：
Better Effectiveness After Transition–Heart Failure (BEAT-HF) Research Group